On February 6, 2018 CymaBay Therapeutics, Inc. (Nasdaq:CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet need, reported that management will participate in upcoming investor conferences, including the SunTrust Robinson Humphrey 4th Annual Orphan Drug Day and the LEERINK Partners 7th Annual Global Healthcare Conference (Press release, CymaBay Therapeutics, FEB 6, 2018, View Source [SID1234523743]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

SunTrust Robinson Humphrey 4th Annual Orphan Drug Day

Date: Tuesday, February 13
Format: One-on-One Format
Location: JW Marriott Essex House, New York City

LEERINK Partners 7th Annual Global Healthcare Conference

Date: Wednesday, February 14
Time: 11:00am Eastern Time
Location: Lotte New York Palace Hotel, New York City
Webcast: View Source